부산대학교 도서관

Garcia-Manero G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Goldberg AD; Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Winer ES; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Altman JK; Robert H Lurie Comprehensive Cancer Center, Chicago, IL, USA.; Fathi AT; Massachusetts General Hospital Cancer Center, Boston, MA, USA.; Odenike O; Section of Hematology/Oncology, Department of Medicine, University of Chicago Medicine, Chicago, IL, USA.; Roboz GJ; Weill Cornell Medicine and the New York Presbyterian Hospital, New York, NY, USA.; Sweet K; Department of Malignant Hematology, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.; Miller C; Aprea Therapeutics, Boston, MA, USA.; Wennborg A; Aprea Therapeutics, Boston, MA, USA.; Hickman DK; Aprea Therapeutics, Boston, MA, USA.; Kanagal-Shamanna R; Department of Hematopathology and Molecular Diagnostics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Kantarjian H; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Lancet J; Department of Malignant Hematology, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.; Komrokji R; Department of Malignant Hematology, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.; Attar EC; Aprea Therapeutics, Boston, MA, USA.; Sallman DA; Department of Malignant Hematology, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA. Electronic address: david.sallman@moffitt.org.

Publisher: Elsevier Ltd Country of Publication: England NLM ID: 101643584 Publication Model: Print Cited Medium: Internet ISSN: 2352-3026 (Electronic) Linking ISSN: 23523026 NLM ISO Abbreviation: Lancet Haematol Subsets: MEDLINE

Mishra A; Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL.; Tamari R; Adult Bone Marrow Transplant Service, Memorial Sloan Kettering Cancer Center, New York, NY.; DeZern AE; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD.; Byrne MT; Division of Hematology and Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN.; Gooptu M; Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.; Chen YB; Hematopoietic Cell Transplant and Cell Therapy Program, Massachusetts General Hospital, Boston, MA.; Deeg HJ; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA.; Sallman D; Malignant Hematology Department, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL.; Gallacher P; Aprea Therapeutics, Boston, MA.; Wennborg A; Aprea Therapeutics, Boston, MA.; Hickman DK; Aprea Therapeutics, Boston, MA.; Attar EC; Aprea Therapeutics, Boston, MA.; Fernandez HF; Moffitt Cancer Center, Pembroke Pines, FL.

Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE

Park H; Division of Oncology, Alvin J Siteman Cancer Center, Washington University, St. Louis, USA. Electronic address: haeseongpark@wustl.edu.; Shapiro GI; Dana Farber Cancer Institute, Department of Medical Oncology, Boston, USA.; Gao X; Massachusetts General Hospital Cancer Center, Boston, USA.; Mahipal A; Division of Medical Oncology, Department of Oncology, Mayo Clinic Cancer Center, Rochester, USA.; Starr J; Division of Hematology/Oncology, Department of Internal Medicine, Mayo Clinic Cancer Center, Jacksonville, USA.; Furqan M; Holden Comprehensive Cancer Center, University of Iowa, Iowa City, USA.; Singh P; Division of Hematology/Oncology, Department of Internal Medicine, Mayo Clinic Cancer Center, Phoenix, USA.; Ahrorov A; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, USA.; Gandhi L; Dana Farber Cancer Institute, Department of Medical Oncology, Boston, USA.; Ghosh A; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, USA.; Hickman D; Aprea Therapeutics, Boston, USA.; Gallacher PD; Aprea Therapeutics, Boston, USA.; Wennborg A; Aprea Therapeutics, Boston, USA.; Attar EC; Aprea Therapeutics, Boston, USA.; Awad MM; Dana Farber Cancer Institute, Department of Medical Oncology, Boston, USA.; Das S; Department of Medicine, Division of Hematology and Oncology, Vanderbilt University Medical Center, Nashville, USA.; Dumbrava EE; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, USA.

Publisher: Elsevier Country of Publication: England NLM ID: 101690685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2059-7029 (Electronic) Linking ISSN: 20597029 NLM ISO Abbreviation: ESMO Open Subsets: MEDLINE

Bazari H; Attar EC; Dahl DM; Uppot RN; Colvin RB; Bazari, Hasan; Attar, Eyal C; Dahl, Douglas M; Uppot, Raul N; Colvin, Robert B

New England Journal of Medicine. 7/29/2010, Vol. 363 Issue 5, p463-475. 13p.

Attar EC; Aquino SL; Hasserjian RP

New England Journal of Medicine. 10/25/2007, Vol. 357 Issue 17, p1745-1754. 10p.

Attar EC; Hasserjian RP

New England Journal of Medicine. 5/11/2006, Vol. 354 Issue 19, p2047-2056. 10p.

Sallman DA; Malignant Hematology Department, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL.; DeZern AE; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD.; Garcia-Manero G; Department of Leukemia, MD Anderson Cancer Center, Houston, TX.; Steensma DP; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.; Roboz GJ; Weill Cornell Medicine and The New York Presbyterian Hospital, New York, NY.; Sekeres MA; Department of Hematology and Medical Oncology, Cleveland Clinic, Cleveland, OH.; Cluzeau T; Cote D'Azur University, Nice Sophia Antipolis University, Hematology Department, CHU Nice, Nice, France.; Sweet KL; Malignant Hematology Department, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL.; McLemore A; Malignant Hematology Department, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL.; McGraw KL; Malignant Hematology Department, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL.; Puskas J; Malignant Hematology Department, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL.; Zhang L; Malignant Hematology Department, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL.; Yao J; Department of Biostatistics and Bioinformatics, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL.; Mo Q; Department of Biostatistics and Bioinformatics, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL.; Nardelli L; Malignant Hematology Department, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL.; Al Ali NH; Malignant Hematology Department, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL.; Padron E; Malignant Hematology Department, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL.; Korbel G; Aprea Therapeutics, Boston, MA.; Attar EC; Aprea Therapeutics, Boston, MA.; Kantarjian HM; Department of Leukemia, MD Anderson Cancer Center, Houston, TX.; Lancet JE; Malignant Hematology Department, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL.; Fenaux P; Hospital St Louis, Assistance Publique-Hôpitaux de Paris, Paris, France.; List AF; Malignant Hematology Department, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL.; Komrokji RS; Malignant Hematology Department, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL.

Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE

Willekens C; Département d'Hématologie, Gustave Roussy, Université Paris-Saclay, Villejuif, France.; Inserm U1170, Gustave Roussy, Université Paris-Saclay, Villejuif, France.; Rahme R; Département d'Hématologie, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris, Paris, France.; Université Paris Diderot, Paris, France.; Inserm U944, Hôpital Saint-Louis, Paris, France.; Duchmann M; Laboratoire d'Hématologie, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris, Université Paris Diderot, Paris, France.; Vidal V; Département d'Hématologie, Hôpital Avicenne, Assistance Publique-Hôpitaux de Paris, Bobigny, France.; Saada V; Département de Biologie et Pathologie médicales, Gustave Roussy, Université Paris-Saclay, Villejuif, France.; Broutin S; Département de Biologie et Pathologie médicales, Gustave Roussy, Université Paris-Saclay, Villejuif, France.; Delahousse J; Département de Biologie et Pathologie médicales, Gustave Roussy, Université Paris-Saclay, Villejuif, France.; Renneville A; Centre de Biologie-Pathologie, Laboratoire d'hématologie, Centre Hospitalier Universitaire de Lille, France.; Marceau A; Centre de Biologie-Pathologie, Laboratoire d'hématologie, Centre Hospitalier Universitaire de Lille, France.; Clappier E; Laboratoire d'Hématologie, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris, Université Paris Diderot, Paris, France.; Uzunov M; Département d'Hématologie, Hôpital Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris, Paris, France.; Rossignol J; Département d'Hématologie, Gustave Roussy, Université Paris-Saclay, Villejuif, France.; Département d'Hématologie, Hôpital Necker-Enfants Malades, Assistance Publique-Hôpitaux de Paris, Paris, France.; Pascal L; Hématologie, Groupement des Hôpitaux de l'Institut Catholique de Lille, Lille, France.; Simon L; Département d'Hématologie, Hôpital universitaire d'Amiens - Picardie, Amiens, France.; Micol JB; Département d'Hématologie, Gustave Roussy, Université Paris-Saclay, Villejuif, France.; Inserm U1170, Gustave Roussy, Université Paris-Saclay, Villejuif, France.; Pasquier F; Département d'Hématologie, Gustave Roussy, Université Paris-Saclay, Villejuif, France.; Inserm U1170, Gustave Roussy, Université Paris-Saclay, Villejuif, France.; Raffoux E; Département d'Hématologie, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris, Paris, France.; Université Paris Diderot, Paris, France.; Inserm U944, Hôpital Saint-Louis, Paris, France.; Preudhomme C; Centre de Biologie-Pathologie, Laboratoire d'hématologie, Centre Hospitalier Universitaire de Lille, France.; Quivoron C; Inserm U1170, Gustave Roussy, Université Paris-Saclay, Villejuif, France.; Itzykson R; Département d'Hématologie, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris, Paris, France.; Université Paris Diderot, Paris, France.; Inserm U944, Hôpital Saint-Louis, Paris, France.; Penard-Lacronique V; Inserm U1170, Gustave Roussy, Université Paris-Saclay, Villejuif, France.; Paci A; Département de Biologie et Pathologie médicales, Gustave Roussy, Université Paris-Saclay, Villejuif, France.; Fenaux P; Département d'Hématologie, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris, Paris, France.; Université Paris Diderot, Paris, France.; Inserm U944, Hôpital Saint-Louis, Paris, France.; Attar EC; Agios Pharmaceuticals, Inc, Cambridge, MA, USA.; Frattini M; Celgene Corporation, Summit, NJ, USA.; Braun T; Département d'Hématologie, Hôpital Avicenne, Assistance Publique-Hôpitaux de Paris, Bobigny, France.; Ades L; Département d'Hématologie, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris, Paris, France.; Université Paris Diderot, Paris, France.; Inserm U944, Hôpital Saint-Louis, Paris, France.; De Botton S; Département d'Hématologie, Gustave Roussy, Université Paris-Saclay, Villejuif, France.; Inserm U1170, Gustave Roussy, Université Paris-Saclay, Villejuif, France.

Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1029-2403 (Electronic) Linking ISSN: 10268022 NLM ISO Abbreviation: Leuk Lymphoma Subsets: MEDLINE

Choe S; Agios Pharmaceuticals, Inc., Cambridge, MA.; Wang H; Agios Pharmaceuticals, Inc., Cambridge, MA.; DiNardo CD; University of Texas MD Anderson Cancer Center, Houston, TX.; Stein EM; Memorial Sloan Kettering Cancer Center, New York, NY.; de Botton S; Department of Hematology, Institut Gustave Roussy, Villejuif, France.; Roboz GJ; Weill Cornell Medicine/New York-Presbyterian Hospital, New York, NY.; Altman JK; Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL.; Mims AS; The Ohio State University Wexner Medical Center, Columbus, OH.; Watts JM; Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL.; Pollyea DA; Division of Hematology, University of Colorado School of Medicine, Aurora, CO.; Fathi AT; Massachusetts General Hospital, Harvard Medical School, Boston, MA.; Tallman MS; Memorial Sloan Kettering Cancer Center, New York, NY.; Kantarjian HM; University of Texas MD Anderson Cancer Center, Houston, TX.; Stone RM; Dana-Farber Cancer Institute, Boston, MA; and.; Quek L; Medical Research Council Molecular Hematology Unit, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, United Kingdom.; Konteatis Z; Agios Pharmaceuticals, Inc., Cambridge, MA.; Dang L; Agios Pharmaceuticals, Inc., Cambridge, MA.; Nicolay B; Agios Pharmaceuticals, Inc., Cambridge, MA.; Nejad P; Agios Pharmaceuticals, Inc., Cambridge, MA.; Liu G; Agios Pharmaceuticals, Inc., Cambridge, MA.; Zhang V; Agios Pharmaceuticals, Inc., Cambridge, MA.; Liu H; Agios Pharmaceuticals, Inc., Cambridge, MA.; Goldwasser M; Agios Pharmaceuticals, Inc., Cambridge, MA.; Liu W; Agios Pharmaceuticals, Inc., Cambridge, MA.; Marks K; Agios Pharmaceuticals, Inc., Cambridge, MA.; Bowden C; Agios Pharmaceuticals, Inc., Cambridge, MA.; Biller SA; Agios Pharmaceuticals, Inc., Cambridge, MA.; Attar EC; Agios Pharmaceuticals, Inc., Cambridge, MA.; Wu B; Agios Pharmaceuticals, Inc., Cambridge, MA.

Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE

Fan B; Agios Pharmaceuticals, Inc., Cambridge, MA, USA. bfan02@hotmail.com.; Dai D; Agios Pharmaceuticals, Inc., Cambridge, MA, USA.; DiNardo CD; University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Stein E; Memorial Sloan Kettering Cancer Center, New York, NY, USA.; de Botton S; Institut Gustave Roussy, Villejuif, France.; Attar EC; Agios Pharmaceuticals, Inc., Cambridge, MA, USA.; Liu H; Agios Pharmaceuticals, Inc., Cambridge, MA, USA.; Liu G; Agios Pharmaceuticals, Inc., Cambridge, MA, USA.; Lemieux I; Agios Pharmaceuticals, Inc., Cambridge, MA, USA.; Agresta SV; Agios Pharmaceuticals, Inc., Cambridge, MA, USA.; Yang H; Agios Pharmaceuticals, Inc., Cambridge, MA, USA.

Publisher: Springer Verlag Country of Publication: Germany NLM ID: 7806519 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0843 (Electronic) Linking ISSN: 03445704 NLM ISO Abbreviation: Cancer Chemother Pharmacol Subsets: MEDLINE